Gene · 64324
Papers2,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thoracic Aortic Disease in Genetic Syndromes Beyond Established Aortopathy Genes. | medRxiv | 2026 | 42818859 | PubTator, text mining | PubMed |
| NSD Histone Methyltransferases in Solid Tumors: Biological Functions, Oncogenic Mechanisms and Therapeutic Targeting. | Int J Mol Sci | 2026 | 42794546 | PubTator, text mining | PubMed |
| Unmasked Behavioral Disturbance Following Traumatic Brain Injury in an Adult With Previously Undiagnosed Sotos Syndrome. | Cureus | 2026 | 42621581 | PubTator, text mining | PubMed |
| Sotos and Malan Syndromes in Childhood: Molecular and Clinical Findings From a Nationwide Cohort of 48 Patients. | Clin Genet | 2026 | 42618064 | PubTator, text mining | PubMed |
| Genetic Etiology and Neurodevelopmental Outcomes in Children With Craniosynostosis: A 15-Year Single-Center Retrospective Study. | J Craniofac Surg | 2026 | 42607197 | PubTator, text mining | PubMed |
| Gonocytes in Transition: Establishing the Male Germline Identity. | Adv Exp Med Biol | 2026 | 42455434 | PubTator, text mining | PubMed |
| Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC): The Role of Histone Methyltransferase and Demethylase Inhibitors. | Cancers (Basel) | 2026 | 42449712 | PubTator, text mining | PubMed |
| Oncogenic PIK3CA mutation enhances tumor immunogenicity through the IRF1-NLRC5-MHC-I axis in urothelial carcinoma. | J Immunother Cancer | 2026 | 42413983 | PubTator, text mining | PubMed |
| Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations. | Cureus | 2026 | 42292729 | PubTator, text mining | PubMed |
| Clinical characterization and developmental follow-up of a child with Sotos syndrome carrying a novel NSD1 variant. | BMC Pediatr | 2026 | 42286513 | PubTator, text mining | PubMed |
| NSD1 governs H3K36me2-mediated DNA methylation and drives endo-mesodermal differentiation of human iPSCs. | Clin Epigenetics | 2026 | 42157059 | PubTator, text mining | PubMed |
| Sotos syndrome: Report of a new pathogenic variant in the NSD1 gene in an adolescent. | Arch Argent Pediatr | 2026 | 42154314 | PubTator, text mining | PubMed |
| Accelerating genetic diagnosis in the NICU: neonatologist-driven rapid whole genome sequencing. | Sci Rep | 2026 | 42141097 | PubTator, text mining | PubMed |
| Spontaneous pneumothorax-associated with genetic disorders. | Ther Adv Respir Dis | 2026 | 41905781 | PubTator, text mining | PubMed |
| Docking of millions: accelerating a million-scale virtual screening using deep learning. | Brief Bioinform | 2026 | 41883032 | PubTator, text mining | PubMed |
| Biallelic Inactivation of NSD1 Associated With Carcinogenesis in Sotos Syndrome. | Pediatr Blood Cancer | 2026 | 41846328 | PubTator, text mining | PubMed |
| Identification of a novel NSD1 pathogenic variant in a Senegalese child with Sotos syndrome. | J Genet Eng Biotechnol | 2026 | 41839667 | PubTator, text mining | PubMed |
| First Korean Case of 5q35.2q35.3 Microduplication With Reversed Sotos Syndrome Phenotype and Growth Hormone Deficiency: Expanding the Endocrine Spectrum. | Am J Med Genet A | 2026 | 41804817 | PubTator, text mining | PubMed |
| DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway. | Oncol Res | 2026 | 41799507 | PubTator, text mining | PubMed |
| NSD1-Mediated PPARγ Methylation Enhances PTEN Activity to Suppress Glycolysis and Tumor Progression in Endometrial Cancer. | Cancer Res | 2026 | 41770031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64324/papers